RhAPPcast
Episodes
Journal Club Review: Ixekizumab vs. Guselkumab in Plaque Psoriasis (12-Week Trial Results)
19 Mar 2025
Contributed by Lukas
Join Jessica Farrell, PharmD, a clinical pharmacist at Albany Med’s Division of Dermatology and professor at Albany College of Pharmacy and Health S...
Medication Review: What is Voclosporin and How Does it Work?
14 Mar 2025
Contributed by Lukas
Join Danielle Gatti Palumbo, Clinical Pharmacist at Northwell Health's Division of Rheumatology in Long Island, New York, as she provides an in-depth ...
FAQ: According to the New 2024 ACR Guidelines for LN, What Are the Treatment Goals For Patients With LN?
13 Mar 2025
Contributed by Lukas
The 2024 ACR guidelines introduce important updates for the screening, treatment, and monitoring of lupus nephritis, with a focus on preserving renal ...
Journal Club Review: Long-Term Safety of Guselkumab in Patients with Psoriatic Disease
12 Mar 2025
Contributed by Lukas
Join Amber Hudgins, PharmD, a pharmacist specializing in rheumatology and specialty pharmacy at Novant Health in Winston-Salem, North Carolina, as she...
RhAPPcast: Navigating Leflunomide Use in Pregnant Patients with Sjögren’s Syndrome
04 Mar 2025
Contributed by Lukas
Join Danielle Gatti Palumbo, PharmD, a clinical pharmacist and RhAPP Board member, alongside Monica Richey, NP, a renowned rheumatology specialist and...
FAQ: According to the New 2024 ACR Guidelines, How Do You Treat LN?
28 Feb 2025
Contributed by Lukas
Stacey Johnson, NP, a rheumatology specialist at Montana Arthritis Center, discusses key updates in the 2024 American College of Rheumatology (ACR) gu...
FAQ: How Do You Interpret cDAPSA/DAPSA and MDA?
26 Feb 2025
Contributed by Lukas
Join Katie Springer, PA-C, a rheumatology specialist at Northwestern Medicine in Lake Forest, Illinois, as she dives into critical tools for measuring...
FAQ: How Do You Explain The Timing of Ixekizumab's Clinical Efficacy to Patients?
19 Feb 2025
Contributed by Lukas
Claudia Rivera Salas, DNP, a nurse practitioner at Pine Hollow Partners in East Lansing, Michigan, shares firsthand insights into the rapid efficacy o...
FAQ: 2024 ACR Guidelines: Screening & Diagnosing Lupus Nephritis in SLE Patients
14 Feb 2025
Contributed by Lukas
Monica Richey, NP, a seasoned rheumatology specialist with two decades of experience, provides an in-depth review of the 2024 lupus nephritis screenin...
RhAPPcast: LN Updates Unpacked: Insights on New ACR Guidelines
11 Feb 2025
Contributed by Lukas
In this episode of RhAPPcast, Amanda Mixon, PA-C, President of RhAPP and a practicing physician assistant in Northern Colorado, is joined by Jennifer ...
FAQ: How is Lupus Nephritis Defined?
07 Feb 2025
Contributed by Lukas
Join Amanda Mixon, PA-C, President of RhAPP and a practicing physician assistant in Northern Colorado, as she highlights the critical role of early de...
FAQ: How Does Real-World Evidence Differ From Randomized Controlled Trials
05 Feb 2025
Contributed by Lukas
Join Jennifer Mylod, NP, from Arizona Arthritis and Rheumatology Associates in Phoenix, as she breaks down the differences between randomized controll...
FAQ: How Long Has It Been Since the Last ACR LN Guideline Updates, and Why Is This Significant?
31 Jan 2025
Contributed by Lukas
Join Amanda Mixon, PA-C, a physician assistant in Northern Colorado and President of RhAPP, as she unpacks the latest ACR guidelines for lupus nephrit...
Journal Club Review: Effectiveness of Methotrexate and Leflunomide as Corticoid-Sparing Drugs
28 Jan 2025
Contributed by Lukas
In this episode, Danielle Gatti Palumbo, PharmD, clinical pharmacist, RhAPP faculty member, and RhAPP Board member, explores a pivotal study evaluatin...
RhAPPcast :The Clinical Utility of Guselkumab in Axial PsA
22 Jan 2025
Contributed by Lukas
In this episode of RhAPPcast, Amanda Mixon, PA-C, President of Rheumatology Advanced Practice Providers (RhAPP), is joined by Audrey Gibson, PA-C, a s...
Journal Club Review: Efficacy & Safety of Ixekizumab ± Methotrexate in PsA (52-Week SPIRIT-H2H)
15 Jan 2025
Contributed by Lukas
Join Amber Hudgins, PharmD, CPP, as she unpacks the findings from the SPIRIT Head-to-Head Study, providing critical insights into biologic therapy sel...
FAQ: How Do You Interpret Radiographic Progression Using Modified-vdHS or mTSS?
08 Jan 2025
Contributed by Lukas
Join Kyle George, PA-C, a rheumatology expert in Idaho, as he breaks down two key radiographic scoring systems for psoriatic arthritis (PsA)—the Mod...
Medication Review: What Is the Efficacy of Ixekizumab Across the GRAPPA and EULAR Domains?
16 Dec 2024
Contributed by Lukas
Join Jessica Farrell, PharmD, Clinical Pharmacist at Albany Medical Center’s Division of Rheumatology and Professor at Albany College of Pharmacy an...
Medication Review: What Is the Safety Profile of Guselkumab in PsO and PsA?
11 Dec 2024
Contributed by Lukas
Join Cassie Dolecki, PharmD, BCPS, Clinical Pharmacy Specialist in Rheumatology at Allegheny Health Network in Pittsburgh, PA, as she reviews the comp...
FAQ: How Does Axial PsA Differ From AS Clinically, Genetically, and Radiographically?
04 Dec 2024
Contributed by Lukas
Join Kyle George, PA-C, a practicing physician assistant in Idaho, as he answers a frequently asked question: How does axial psoriatic arthritis (Axia...
Journal Club Review: 6-Month Guselkumab Effectiveness in PsA (Real-World CorEvitas Data)
20 Nov 2024
Contributed by Lukas
Join Jessica Farrell, PharmD, clinical pharmacist at Albany Medical Center’s Division of Rheumatology and faculty at Albany College of Pharmacy and ...
RhAPPcast: Navigating the Complexities: IL-17 Inhibitors and IBD Risk
13 Nov 2024
Contributed by Lukas
Join Amanda Mixon, PA-C, President of RhAPP, and Candace Ryan, PA-C, as they explore the evolving discussion around IL-17 inhibitors and their potenti...
FAQ: Why is Binding CD64+ Important When Discussing IL23 Directed Therapy
06 Nov 2024
Contributed by Lukas
Join Heather Mambretti, PA-C, a rheumatology expert in Houston, Texas, and RhAPP member, as she explores the critical role of CD64-positive binding in...
Journal Club Review: Upadacitinib Safety & Efficacy in Pediatric JIA (Phase-1 Interim Data)
04 Nov 2024
Contributed by Lukas
Join Ingrid Pan, PharmD, Pediatric Clinical Pharmacist at Children’s Hospital Colorado, as she reviews the latest findings from the Phase 1 trial of...
RhAPPcast: Lost Time: The Impact of Delaying Optimal Therapy in RA & SpA Patients Without Disease Control
01 Nov 2024
Contributed by Lukas
In this RhAPPcast episode, host Amanda Mixon, PA-C, welcomes Jeannette Hart, PA-C, a seasoned rheumatology provider and RhAPP faculty member, to explo...
Journal Club Review: 5-Year Data on Switching Upadacitinib & Adalimumab in RA
30 Oct 2024
Contributed by Lukas
Join Jessica Farrell, PharmD, Clinical Pharmacist at Albany Med’s Division of Rheumatology and Professor at Albany College of Pharmacy and Health Sc...
FAQ: Definition of Remission in Rheumatoid Arthritis & Likelihood with Advanced Therapies
25 Oct 2024
Contributed by Lukas
Join Stacey Johnson, NP-C, as she explains the two primary remission criteria for rheumatoid arthritis (RA) recommended by the American College of Rhe...
Medication Review: How is Guselkumab dosed in PsO, PsA, and IBD
23 Oct 2024
Contributed by Lukas
Join Danielle Gatti Palumbo, PharmD, clinical pharmacist at Northwell Health, Division of Rheumatology in Long Island, New York, as she provides an in...
RhAPPcast: Navigating Remission in Rheumatoid Arthritis: Approaches, Advances, Impact, and Insights
18 Oct 2024
Contributed by Lukas
Welcome to RhAPPcast, the official podcast for Rheumatology Advanced Practice Providers (RhAPP). In this episode, Amanda Mixon, PA-C, RhAPP President,...
FAQ: Variability in JAK Inhibition Specificity & Its Clinical Implications
16 Oct 2024
Contributed by Lukas
Join Dr. Claudia Rivera Salas, DNP, NP-C, a rheumatology nurse practitioner in East Lansing, Michigan, as she explores the variability in JAK enzyme i...
RhAPPcast: CD64+ Binding Description, Relevance, and Potential Clinical Implications
16 Oct 2024
Contributed by Lukas
Welcome to RhAPPcast, the official podcast for Rheumatology Advanced Practice Providers (RhAPP). In this episode, Amanda Mixon, PA-C, RhAPP President,...
FAQ: What Is the Difference Between Biosimilars and Generics?
14 Oct 2024
Contributed by Lukas
Join Kyle George, PA-C, a rheumatology specialist in Idaho, as he clarifies the fundamental differences between biosimilars and generic drugs—an ess...
FAQ: What Is the ORAL Surveillance Study and How Can It Be Applied to Clinical Practice?
11 Oct 2024
Contributed by Lukas
Join Heather Mambretti, PA-C, a rheumatology specialist in Houston, Texas, as she breaks down the key findings of the Oral Surveillance Study and disc...
FAQ: What is the Safety Profile of Ixekizumab in PsA and axSpa
09 Oct 2024
Contributed by Lukas
Wendy Simmons, PA-C, a rheumatology specialist at Carolina Arthritis Associates in Wilmington, North Carolina, explores the safety profile of Ixekizum...
Medication Review: What Is the Safety Profile of Upadacitinib Across Indications?
07 Oct 2024
Contributed by Lukas
Join Jessica Farrell, PharmD, a clinical pharmacist at Albany Med's Division of Rheumatology and professor at Albany College of Pharmacy and Health Sc...
FAQ: Provide Immunologic Rationale For IL23 Directed Therapy in PsA, PsO, and IBD.
02 Oct 2024
Contributed by Lukas
Join Heather Mambretti, PA-C, a rheumatology specialist in Houston, Texas, as she explores the critical role of IL-23 in autoimmune disease pathogenes...
RhAPPcast: Biosimilars and The Patient Perspective
30 Sep 2024
Contributed by Lukas
Welcome to RhAPPcast, the official voice of Rheumatology Advanced Practice Providers (RhAPP). In this special episode, Amanda Mixon, PA-C, RhAPP Presi...
Medication Review: How Is Upadacitinib Dosed Across Rheumatologic Indications?
19 Sep 2024
Contributed by Lukas
Join Kyle George, PA-C, a rheumatology physician assistant in Idaho, as he reviews the dosing recommendations for Upadacitinib (Rinvoq) across rheumat...
FAQ: Provide Immunologic Rationale for JAK-Directed Therapy in Rheumatic Disease
17 Sep 2024
Contributed by Lukas
Join Dr. Claudia Rivera Salas, DNP, NP-C, a rheumatology nurse practitioner in East Lansing, Michigan, as she explores the immunologic rationale behin...
Medication Review: Describe the Mechanism of Action of Upadacitinib
13 Sep 2024
Contributed by Lukas
Join Ingrid Pan, PharmD, a pediatric clinical pharmacist at Children’s Hospital Colorado, as she explores the mechanism of action of Upadacitinib (R...
FAQ: Provide Immunologic Rationale For IL17-Directed Therapy in PsA, AS, and nr-axSpA
11 Sep 2024
Contributed by Lukas
Join Kyle George, PA-C, a rheumatology specialist in Idaho, as he examines the immunologic basis for IL-17 inhibition in treating psoriatic arthritis ...
FAQ: Describe the IL17-Induced Inflammatory Cascade
04 Sep 2024
Contributed by Lukas
Join Robert Laugherty, PA-C, JD, a rheumatology specialist with over 16 years of experience, as he explores IL-17, a key cytokine involved in immune d...
FAQ: Describe JAK-STAT Signaling in Inflammation
04 Sep 2024
Contributed by Lukas
Join Heather Mambretti, PA-C, a rheumatology specialist with over 12 years of experience in the Houston Metro area, as she provides an in-depth look a...
FAQ: What Does It Mean for a Biosimilar to Be Interchangeable and Why Is That Important?
02 Sep 2024
Contributed by Lukas
Join Kyle George, PA-C, a rheumatology specialist in Idaho, as he explores the critical role of interchangeable biosimilars in modern healthcare. Bios...
Journal Club Review: Long-Term Efficacy and Safety of Guselkumab
28 Aug 2024
Contributed by Lukas
Join Amber Hudgins, PharmD, a pharmacist specializing in rheumatology and specialty pharmacy at Novant Health in Winston-Salem, North Carolina, as she...
Medication Review: What is Non-Responder Imputation and How is it Utilized in Clinical Trials
21 Aug 2024
Contributed by Lukas
Join Danielle Gatti Palumbo, PharmD, a clinical pharmacist at Northwell Health’s Division of Rheumatology in Long Island, New York, as she explains ...
RhAPPcast: Biosimilars Unveiled - Empowering APPs for Better Patient Conversations
19 Aug 2024
Contributed by Lukas
Welcome to RhAPPcast, the official podcast of Rheumatology Advanced Practice Providers (RhAPP). In this episode, Amanda Mixon, PA-C, President of RhAP...
Medication Review: Describe The Mechanism of Action of Ixekizumab
14 Aug 2024
Contributed by Lukas
Christy Vath, PA-C, from Seattle Rheumatology in Washington, provides a concise yet insightful overview of the mechanism of action of Ixekizumab, a ta...
FAQ: What is The Role of IL23/IL17 Axis in Rheumatic Disease
07 Aug 2024
Contributed by Lukas
Join Katie Springer, PA-C, from Northwestern Medicine in Lake Forest, Illinois, as she explores the critical role of the IL-23/IL-17 axis in immune-me...
RhAPPcast: The IL23/IL17 Cascade and Implications in the Pathogenesis of PsA, PsO, and IBD
17 Jul 2024
Contributed by Lukas
Amanda Mixon, PA-C, President of RhAPP, is joined by Christy Vath, PA-C, an expert in immunology and rheumatology, to explore the IL-23/IL-17 pathway ...
The 2024 RhAPP National Conference in Nashville, TN
10 Jul 2024
Contributed by Lukas
Get ready for an exclusive preview of the 2024 RhAPP National Conference in Nashville, Tennessee, happening from September 26-28, 2024! In this specia...
FAQ: Describe The IL23/IL17 Axis
03 Jul 2024
Contributed by Lukas
Join Katie Springer, PA-C, a rheumatology specialist at Northwestern Medicine in Lake Forest, Illinois, as she presents an in-depth exploration of the...
Journal Club Review: Differentiation of Therapeutic Antibodies Targeting Interleukin (IL)-23
20 Jun 2024
Contributed by Lukas
Join Amber Hudgins, PharmD, a clinical pharmacist at Novant Health in Winston-Salem, North Carolina, presents an in-depth analysis of IL-23 inhibitors...
Medication Review: Describing the Mechanism of Action of Guselkumab
13 Jun 2024
Contributed by Lukas
Join Danielle Gatti Palumbo, PharmD, a clinical pharmacist at Northwell Health’s Division of Rheumatology in Long Island, New York, as she provides ...
FAQ: Define, compare, and contrast humoral and cell-mediated immunity.
06 Jun 2024
Contributed by Lukas
In this educational FAQ video, Katie Springer, PA-C, from Northwestern Medicine at Lake Forest Hospital, Illinois, provides a clear and concise breakd...
RhAPPcast Spotlight: Clinical Cornerstones with Lindsay Tom, PA-C
29 May 2024
Contributed by Lukas
Join RhAPPcast for an enlightening episode featuring Lindsay Tom, PA-C, as we highlight the latest Spotlight: Clinical Cornerstones segment from RhAPP...
RhAPPcast Spotlight: Clinical Cornerstones with Cayla Alexander, DNP, ARNP
29 Apr 2024
Contributed by Lukas
Join RhAPPcast for an insightful episode featuring Cayla Alexander, DNP, ARNP, as we highlight the latest Spotlight: Clinical Cornerstones segment fro...
Breathing New Life: HRCT and PFTs in ILD with Corinne Young of APAPP
02 Apr 2024
Contributed by Lukas
Join RhAPPcast for an essential deep dive into the intersection of rheumatology and pulmonology, featuring Corinne Young, MSN, FNP-C, FCCP, president ...
Spotlight: Clinical Cornerstones, Mary Elliott, PA-C
07 Feb 2024
Contributed by Lukas
Join RhAPPcast for an insightful episode featuring Mary Elliott, PA-C, as part of RhAPP’s Clinical Cornerstones Spotlight series. Hosted by Amanda M...
Leading the Way: Dr. John Cush on Rheumatology Leadership
17 Jan 2024
Contributed by Lukas
In this insightful episode of RhAPPcast, host Amanda Mixon, PA-C, sits down with Dr. Jack Cush, a leading rheumatologist and the program chair of Rheu...
Discussing Biosimilars With Patients
13 Dec 2023
Contributed by Lukas
In the twelfth and final episode of the GHAPP & RhAPP biosimilar podcast series, host Gabriella McCarty, NP, sits down with Jamie Brogan, NP, for ...
The Nocebo Effect
08 Dec 2023
Contributed by Lukas
Welcome to our eleventh episode of the GHAPP & RhAPP biosimilar podcast series! Our host Amanda Mixon, PA-C, engages in an insightful conversation...
Voices for Change: Madelaine Feldman, MD of CSRO on Advocacy in Rheumatology
30 Nov 2023
Contributed by Lukas
Join host Amanda Mixon, PA-C, in an insightful episode of RhAPPcast, featuring Madelaine Feldman, MD, a leading rheumatologist and passionate advocate...
The Practical Use of Biosimilars in Gastroenterology APP Practice
08 Nov 2023
Contributed by Lukas
In the tenth episode of the GHAPP & RhAPP Biosimilar Podcast Series, host Gabriella McCarty, NP-C, welcomes Sharon Dudley-Brown, PhD, FNP-BC, FAAN...
The Practical Use of Biosimilars in Rheumatology APP Practice
30 Oct 2023
Contributed by Lukas
In the ninth episode of the GHAPP & RhAPP Biosimilar Podcast Series, host Amanda Mixon, PA-C, welcomes guest Daric Mueller, PA-C, for an engaging ...
The Benefits of Biosimilars
11 Oct 2023
Contributed by Lukas
The latest episode of the GHAPP & RhAPP Biosimilar Podcast Series, hosted by Gabriella McCarty, NP, welcomes guest expert Gwen Cassidy, NP, for an...
Managed Care and Biosimilars
03 Oct 2023
Contributed by Lukas
The latest episode of the GHAPP & RhAPP Biosimilar Podcast Series, hosted by Amanda Mixon, PA-C, dives into a critical conversation on the interpl...
Interchangeability & Switching of Biosimilars
15 Sep 2023
Contributed by Lukas
In the latest episode of the GHAPP & RhAPP Biosimilar Podcast Series, host Gabriella McCarty, NP-C, is joined by Janette Villalon, NP, to discuss ...
Spotlight: Clinical Cornerstones, Daric Mueller, MS, PA-C
30 Aug 2023
Contributed by Lukas
The latest episode of RhAPPcast brings you a compelling discussion inspired by RhAPP’s quarterly newsletter segment, Clinical Cornerstones Spotlight...
Biosimilar Extrapolation
23 Aug 2023
Contributed by Lukas
The fifth episode of the GHAPP & RhAPP Biosimilar Podcast Series takes a deep dive into one of the most crucial yet often misunderstood aspects of...
The Difference Between Biosimilars & Generic Drugs
08 Aug 2023
Contributed by Lukas
In the fourth episode of the GHAPP & RhAPP Biosimilar Podcast Series, host Gabriella McCarty, NP, is joined by Tedra Gray, NP, for an in-depth dis...
The Regulatory Pathway to Biosimilar Approval
25 Jul 2023
Contributed by Lukas
Join us for the third episode of the GHAPP & RhAPP Biosimilar Podcast Series, where host Amanda Mixon, PA-C, engages in an insightful conversation...
Development of Biosimilars
13 Jul 2023
Contributed by Lukas
Join us for the second episode of the GHAPP & RhAPP Biosimilar Podcast Series, where host Amanda Mixon, PA-C, sits down with Tanya Golovanoff, Pha...
From Idea to Impact: The RhAPP Origin Story
22 Jun 2023
Contributed by Lukas
Join RhAPP co-founders Amanda Mixon, PA-C, and Betsy Kirchner, DNP, as they take you on a journey through the inspiring origins of RhAPP, a groundbrea...
Biosimilars Series: What Are Biosimilars?
14 Jun 2023
Contributed by Lukas
Join us for the first episode of the GHAPP & RhAPP biosimilar podcast series! In this episode Gabriella McCarty, NP-C is joined by Jennifer Geremi...